SELLAS Life Sciences (SLS) Accounts Payables (2019 - 2024)
SELLAS Life Sciences (SLS) has disclosed Accounts Payables for 9 consecutive years, with $4.5 million as the latest value for Q3 2024.
- Quarterly Accounts Payables rose 4.77% to $4.5 million in Q3 2024 from the year-ago period, while the trailing twelve-month figure was $4.5 million through Sep 2024, up 4.77% year-over-year, with the annual reading at $5.6 million for FY2023, 67.98% up from the prior year.
- Accounts Payables for Q3 2024 was $4.5 million at SELLAS Life Sciences, down from $6.3 million in the prior quarter.
- The five-year high for Accounts Payables was $7.4 million in Q1 2024, with the low at $1.8 million in Q3 2020.
- Average Accounts Payables over 5 years is $3.6 million, with a median of $3.1 million recorded in 2023.
- The sharpest move saw Accounts Payables plummeted 53.96% in 2021, then soared 139.01% in 2024.
- Over 5 years, Accounts Payables stood at $4.7 million in 2020, then crashed by 53.96% to $2.1 million in 2021, then surged by 56.58% to $3.4 million in 2022, then surged by 67.98% to $5.6 million in 2023, then dropped by 19.37% to $4.5 million in 2024.
- According to Business Quant data, Accounts Payables over the past three periods came in at $4.5 million, $6.3 million, and $7.4 million for Q3 2024, Q2 2024, and Q1 2024 respectively.